FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021106512> ?p ?o ?g. }

• W2021106512 endingPage "622" @default.
• W2021106512 startingPage "615" @default.
• W2021106512 abstract "Respiratory Syncytial Virus (RSV) is a ubiquitous virus that infects almost all people by age two and is a major source of respiratory illness in infants, the elderly and others with compromised immune systems. Currently there is no available vaccine. Prior efforts using formalin-inactivated RSV (FI-RSV) were associated with enhanced respiratory disease upon viral exposure following clinical vaccine trials. Several researchers and pharmaceutical companies have utilized vector-associated live attenuated RSV vaccines in pre-clinical and clinical studies. Another attractive approach, however, is a subunit vaccine which would be easier to produce and quality control. Our group has previously demonstrated in a murine model of infection that intranasal immunization with nanoemulsion-inactivated and adjuvanted RSV induces humoral and cellular immune responses, resulting in protection against RSV infection. The present studies characterize the immune responses elicited by intranasal RSV F protein adjuvanted with nanoemulsion. Intranasal application of nanoemulsion adjuvanted F protein induced a rapid and robust systemic and mucosal antibody response, as well as protection against subsequent RSV challenge. Importantly, RSV challenge in immunized animals did not elicit airway hyper-reactivity, a Th2-skewed immune response or immunopathology associated with hypersensitivity reactions with formalin-inactivated vaccine. These results suggest that RSV F protein adjuvanted with nanoemulsion may be a good mucosal vaccine candidate. Formulating RSV F protein in nanoemulsion creates a well-defined and well-controlled vaccine that can be delivered intranasally to induce T cell mediated immunity without inducing enhanced disease associated with the mouse model of FI-RSV vaccination and infection." @default.
• W2021106512 created "2016-06-24" @default.
• W2021106512 creator A5001815561 @default.
• W2021106512 creator A5001853619 @default.
• W2021106512 creator A5006821273 @default.
• W2021106512 creator A5013132932 @default.
• W2021106512 creator A5013510010 @default.
• W2021106512 creator A5020488186 @default.
• W2021106512 creator A5028046133 @default.
• W2021106512 creator A5034045203 @default.
• W2021106512 creator A5048688552 @default.
• W2021106512 creator A5049138501 @default.
• W2021106512 creator A5084562888 @default.
• W2021106512 date "2013-12-10" @default.
• W2021106512 modified "2023-09-27" @default.
• W2021106512 title "Intranasal immunization with W₈₀5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model" @default.
• W2021106512 cites W1483394691 @default.
• W2021106512 cites W1547464573 @default.
• W2021106512 cites W1840633113 @default.
• W2021106512 cites W1925238017 @default.
• W2021106512 cites W1966336443 @default.
• W2021106512 cites W1968715103 @default.
• W2021106512 cites W1969686369 @default.
• W2021106512 cites W1972577557 @default.
• W2021106512 cites W1978192417 @default.
• W2021106512 cites W1986189079 @default.
• W2021106512 cites W1990295383 @default.
• W2021106512 cites W2002214614 @default.
• W2021106512 cites W2008833045 @default.
• W2021106512 cites W2012066032 @default.
• W2021106512 cites W2020830257 @default.
• W2021106512 cites W2028532590 @default.
• W2021106512 cites W2031967641 @default.
• W2021106512 cites W2043901139 @default.
• W2021106512 cites W2044706598 @default.
• W2021106512 cites W2051145409 @default.
• W2021106512 cites W2051682127 @default.
• W2021106512 cites W2055180355 @default.
• W2021106512 cites W2072746681 @default.
• W2021106512 cites W2076361043 @default.
• W2021106512 cites W2081426187 @default.
• W2021106512 cites W2085738463 @default.
• W2021106512 cites W2100990607 @default.
• W2021106512 cites W2104073676 @default.
• W2021106512 cites W2104831689 @default.
• W2021106512 cites W2106471879 @default.
• W2021106512 cites W2108274821 @default.
• W2021106512 cites W2119636028 @default.
• W2021106512 cites W2120949068 @default.
• W2021106512 cites W2122557423 @default.
• W2021106512 cites W2124190972 @default.
• W2021106512 cites W2134249387 @default.
• W2021106512 cites W2139677262 @default.
• W2021106512 cites W2139841187 @default.
• W2021106512 cites W2144021590 @default.
• W2021106512 cites W2158904597 @default.
• W2021106512 cites W2161554633 @default.
• W2021106512 doi "https://doi.org/10.4161/hv.27383" @default.
• W2021106512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4130273" @default.
• W2021106512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24326268" @default.
• W2021106512 hasPublicationYear "2013" @default.
• W2021106512 type Work @default.
• W2021106512 sameAs 2021106512 @default.
• W2021106512 citedByCount "13" @default.
• W2021106512 countsByYear W20211065122015 @default.
• W2021106512 countsByYear W20211065122018 @default.
• W2021106512 countsByYear W20211065122019 @default.
• W2021106512 countsByYear W20211065122020 @default.
• W2021106512 countsByYear W20211065122021 @default.
• W2021106512 countsByYear W20211065122023 @default.
• W2021106512 crossrefType "journal-article" @default.
• W2021106512 hasAuthorship W2021106512A5001815561 @default.
• W2021106512 hasAuthorship W2021106512A5001853619 @default.
• W2021106512 hasAuthorship W2021106512A5006821273 @default.
• W2021106512 hasAuthorship W2021106512A5013132932 @default.
• W2021106512 hasAuthorship W2021106512A5013510010 @default.
• W2021106512 hasAuthorship W2021106512A5020488186 @default.
• W2021106512 hasAuthorship W2021106512A5028046133 @default.
• W2021106512 hasAuthorship W2021106512A5034045203 @default.
• W2021106512 hasAuthorship W2021106512A5048688552 @default.
• W2021106512 hasAuthorship W2021106512A5049138501 @default.
• W2021106512 hasAuthorship W2021106512A5084562888 @default.
• W2021106512 hasBestOaLocation W20211065121 @default.
• W2021106512 hasConcept C126322002 @default.
• W2021106512 hasConcept C159047783 @default.
• W2021106512 hasConcept C203014093 @default.
• W2021106512 hasConcept C22070199 @default.
• W2021106512 hasConcept C2522874641 @default.
• W2021106512 hasConcept C2779341262 @default.
• W2021106512 hasConcept C2780355102 @default.
• W2021106512 hasConcept C2780727368 @default.
• W2021106512 hasConcept C2780801004 @default.
• W2021106512 hasConcept C2780813555 @default.
• W2021106512 hasConcept C534529494 @default.
• W2021106512 hasConcept C71924100 @default.
• W2021106512 hasConcept C85663871 @default.
• W2021106512 hasConcept C8891405 @default.
• W2021106512 hasConceptScore W2021106512C126322002 @default.

• next